Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Steroid use and misuse: a key performance indicator in the management of IBD

Blackwell, J; Selinger, CP; Raine, T; Parkes, GC; Smith, M; Pollok, RCG (2020) Steroid use and misuse: a key performance indicator in the management of IBD. Frontline Gastroenterology. ISSN 2041-4137
SGUL Authors: Pollok, Richard Charles G

[img] Microsoft Word (.docx) Accepted Version
Available under License ["licenses_description_publisher" not defined].

Download (138kB)


Corticosteroids remain an important tool for inducing remission in inflammatory bowel disease (IBD) but they have no role in maintenance of remission. The significant adverse side effect profile of these drugs means their use should be avoided where possible or measures taken to reduce their risk. Despite an expanding array of alternative therapies, corticosteroid dependency and excess remain common. Appropriate steroid use is now regarded a key performance indicator in the management of IBD. This article aims to outline indications for corticosteroid use in IBD, their risks and strategies to reduce their use and misuse.

Item Type: Article
Additional Information: This article has been accepted for publication in Frontline Gastroenterology, 2020 following peer review, and the Version of Record can be accessed online at © Author(s) (or their employer(s)) 2020.
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: Frontline Gastroenterology
ISSN: 2041-4137
2 April 2020Published Online
18 March 2020Accepted
Publisher License: Publisher's own licence
Project IDFunderFunder ID
SP2018/3Crohn's and Colitis UK
Publisher's version:

Actions (login required)

Edit Item Edit Item